Indefinite Delivery Contract SPE2DR25D2102

The federal contract IDV award SPE2DR25D2102 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and supports the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical and medical supply support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers an extensive array of medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. It serves as a primary vehicle for efficient government procurement of essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. The original solicitation for this IDC was an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation method, seeking to establish multiple regional primary supplier contracts and a backup supplier contract to enhance the DoD's resiliency and access to vital pharmaceuticals.